Implantable Collamer Lens Market Report 2026

Implantable Collamer Lens Market Overview

• Implantable Collamer Lens market size has reached to $20.77 billion in 2025 • Expected to grow to $28.74 billion in 2030 at a compound annual growth rate (CAGR) of 6.7% • Growth Driver: Rising Prevalence Of Vision Disorders Driving Growth In The Implantable Collamer Lens Market • Market Trend: Advancements in Implantable Collamer Lenses For Minimally Invasive Vision Correction • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Implantable Collamer Lens Market?

Implantable collamer lenses (ICLs), often referred to as implantable contact lenses, are refractive lens implants that are placed into the eye to treat various disorders. It works just like a contact lens, with the exception that it is surgically placed in front of your natural lens and behind the iris, the colored portion of the eye. The main types of implantable collamer lens are visian implantable collamer lens (ICL) and EVO implantable collamer lens (ICL). Visian ICL (Implantable Collamer Lens) is a phakic intraocular lens used to correct vision issues like myopia, hyperopia, and astigmatism, offering a reversible and biocompatible alternative to LASIK surgery. These lenses adopted technology such as laser-assisted techniques and traditional techniques. In terms of application, they are primarily used for myopia, hyperopia, and astigmatism and is used by several end users, including ophthalmic clinics, hospitals, ambulatory surgical centers, and other end users.

What Is The Implantable Collamer Lens Market Growth Forecast?

The implantable collamer lens market size is expected to see strong growth in the next few years. It will grow to $28.74 billion in 2030 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to increasing adoption of premium vision correction solutions, rising focus on minimally invasive ophthalmic surgeries, expansion of elective eye care procedures, growing investments in advanced ophthalmology technologies, increasing patient awareness of icl benefits. Major trends in the forecast period include increasing adoption of evo implantable collamer lenses, rising use of laser-assisted implantation techniques, growing demand for reversible vision correction solutions, expansion of customized lens designs, enhanced focus on long-term visual stability.

Global Implantable Collamer Lens Market Segmentation

1) By Type: Visian Implantable Collamer Lens (ICL), EVO Implantable Collamer Lens (ICL) 2) By Technology Adoption: Laser-Assisted Techniques, Traditional Techniques 3) By Application: Myopia, Hyperopia, Astigmatism 4) By End User: Ophthalmic Clinics, Hospitals, Ambulatory Surgical Center, Other End User Subsegments: 1) By Visian Implantable Collamer Lens (ICL): Visian ICL for Myopia, Visian ICL For Hyperopia, Visian ICL For Astigmatism, Visian ICL For Presbyopia 2) By EVO Implantable Collamer Lens (ICL): EVO ICL For Myopia, EVO ICL For Hyperopia, EVO ICL For Astigmatism, EVO ICL For Presbyopia

What Is The Driver Of The Implantable Collamer Lens Market?

The rising prevalence of vision disorders is expected to drive the implantable collamer lens market going forward. Vision disorders refer to conditions that affect the ability to see clearly, characterized by a gradual decline in visual acuity and eye health. Vision disorders are increasing globally due to factors such as an aging population, increased screen time, and rising prevalence of conditions like myopia and age-related macular degeneration. Implantable Collamer Lenses (ICLs) provide an effective solution for correcting vision disorders such as myopia, hyperopia, and astigmatism by offering a safe, reversible alternative to traditional refractive surgeries like LASIK. For instance, in August 2023, according to a report published by the World Health Organization, a Switzerland-based specialized agency of the United Nations, globally, over 2.2 billion people suffer from near or distance vision impairment, with 1 billion of these cases being preventable or still unaddressed. Therefore, the increasing prevalence of vision disorders is driving the growth of the implantable collamer lens industry.

Key Players In The Global Implantable Collamer Lens Market

Major companies operating in the implantable collamer lens market are STAAR Surgical Company, Care Group Sight Solutions (IPCL), Ophtec (Artisan Phakic IOLs), Rayner Surgical, Hoya Surgical Optics, Alcon Inc., Johnson & Johnson Vision/Abbott Medical Optics, Bausch + Lomb, Carl Zeiss Meditec AG, Nidek Co. Ltd., Lenstec Inc., SIFI S.p.A., Optimedical, Eyeonics (now part of Santen)*, Physiol LLC, Microlens Tech Co. Ltd., HumanOptics AG, Ocular Instruments Inc., Aaren Scientific LLC, Visiogen Inc.

Global Implantable Collamer Lens Market Trends and Insights

Major companies operating in the implantable collamer lens market are focusing on technological innovation, such as biocompatible, minimally invasive lens implants that correct a wide range of refractive errors without removing corneal tissue, to improve patient outcomes and reduce dependence on glasses and contact lenses. Biocompatible Minimally Invasive Implantable Lenses enable safe, reversible vision correction by working with the natural anatomy of the eye, offering rapid procedures and high patient satisfaction. For instance, in March 2024, STAAR Surgical Company, a U.S.-based ophthalmic medical device company, announced that over three million EVO ICL lenses have been implanted globally. The EVO ICL corrects myopia, with or without astigmatism, and presbyopia, using a 20–30 minute procedure that places the lens between the iris and the natural crystalline lens. The biocompatible, removable lens provides a next-generation alternative to glasses and contacts, helping millions of patients achieve improved vision safely and effectively.

What Are Latest Mergers And Acquisitions In The Implantable Collamer Lens Market?

In May 2025, Alcon, a Switzerland-based eye care company, acquired STAAR Surgical, for approximately $1.5 billion. With this acquisition, Alcon aims to expand its surgical vision correction portfolio, complementing its laser vision correction business and providing solutions for patients with moderate to high myopia. STAAR Surgical Company is a U.S.-based medical device company that offers implantable collamer lens.

Regional Outlook

North America was the largest region in the implantable collamer lens market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Implantable Collamer Lens Market?

The implantable collamer lens (ICL) market consists of sales of lenses, ICL delivery systems, surgical equipment, and preoperative diagnostic tools. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.